Medical Professionals

our clinical trials

bluebird bio is conducting clinical studies of investigational gene therapies in four diseases: transfusion-dependent β-thalassemia, severe sickle cell disease, cerebral adrenoleukodystrophy, and relapsed/refractory multiple myeloma.

For more information, follow the links below to the study listings on Medical professionals may also email us at for more information about study participation.


Learn more about our ongoing clinical trials: